These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32940072)

  • 1. Ingestion-time - relative to circadian rhythms - differences in the pharmacokinetics and pharmacodynamics of hypertension medications.
    Hermida RC; Hermida-Ayala RG; Smolensky MH; Mojón A; Fernández JR
    Expert Opin Drug Metab Toxicol; 2020 Dec; 16(12):1159-1173. PubMed ID: 32940072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of time-of-day of hypertension treatment on ambulatory blood pressure and clinical characteristics of patients with type 2 diabetes.
    Moyá A; Crespo JJ; Ayala DE; Ríos MT; Pousa L; Callejas PA; Salgado JL; Mojón A; Fernández JR; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):116-31. PubMed ID: 23181613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated asleep blood pressure and non-dipper 24h patterning best predict risk for heart failure that can be averted by bedtime hypertension chronotherapy: A review of the published literature.
    Hermida RC; Mojón A; Fernández JR; Hermida-Ayala RG; Crespo JJ; Ríos MT; Domínguez-Sardiña M; Otero A; Smolensky MH
    Chronobiol Int; 2023 Jan; 40(1):63-82. PubMed ID: 34190016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration-time-dependent effects of hypertension treatment on ambulatory blood pressure in patients with chronic kidney disease.
    Crespo JJ; Piñeiro L; Otero A; Castiñeira C; Ríos MT; Regueiro A; Mojón A; Lorenzo S; Ayala DE; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):159-75. PubMed ID: 23098134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2010 Sep; 27(8):1629-51. PubMed ID: 20854139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines for the design and conduct of human clinical trials on ingestion-time differences - chronopharmacology and chronotherapy - of hypertension medications.
    Hermida RC; Smolensky MH; Balan H; Castriotta RJ; Crespo JJ; Dagan Y; El-Toukhy S; Fernández JR; FitzGerald GA; Fujimura A; Geng YJ; Hermida-Ayala RG; Machado AP; Menna-Barreto L; Mojón A; Otero A; Rudic RD; Schernhammer E; Skarke C; Steen TY; Young ME; Zhao X
    Chronobiol Int; 2021 Jan; 38(1):1-26. PubMed ID: 33342316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review and quality evaluation of published human ingestion-time trials of blood pressure-lowering medications and their combinations.
    Hermida RC; Hermida-Ayala RG; Mojón A; Smolensky MH; Fernández JR
    Chronobiol Int; 2021 Oct; 38(10):1460-1476. PubMed ID: 34107831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment-time regimen of hypertension medications significantly affects ambulatory blood pressure and clinical characteristics of patients with resistant hypertension.
    Hermida RC; Ríos MT; Crespo JJ; Moyá A; Domínguez-Sardiña M; Otero A; Sánchez JJ; Mojón A; Fernández JR; Ayala DE;
    Chronobiol Int; 2013 Mar; 30(1-2):192-206. PubMed ID: 23098160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ingestion-time differences in the pharmacodynamics of hypertension medications: Systematic review of human chronopharmacology trials.
    Hermida RC; Hermida-Ayala RG; Smolensky MH; Mojón A; Fernández JR
    Adv Drug Deliv Rev; 2021 Mar; 170():200-213. PubMed ID: 33486007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extent of asleep blood pressure reduction by hypertension medications is ingestion-time dependent: Systematic review and meta-analysis of published human trials.
    Hermida RC; Mojón A; Hermida-Ayala RG; Smolensky MH; Fernández JR
    Sleep Med Rev; 2021 Oct; 59():101454. PubMed ID: 33571840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sleep-time blood pressure: Unique sensitive prognostic marker of vascular risk and therapeutic target for prevention.
    Hermida RC; Ayala DE; Smolensky MH; Fernández JR; Mojón A; Portaluppi F
    Sleep Med Rev; 2017 Jun; 33():17-27. PubMed ID: 27316324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration-time differences in effects of hypertension medications on ambulatory blood pressure regulation.
    Hermida RC; Ayala DE; Fernández JR; Mojón A; Smolensky MH; Fabbian F; Portaluppi F
    Chronobiol Int; 2013 Mar; 30(1-2):280-314. PubMed ID: 23077971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New perspectives on the definition, diagnosis, and treatment of true arterial hypertension.
    Hermida RC; Smolensky MH; Mojón A; Crespo JJ; Ríos MT; Domínguez-Sardiña M; Otero A; Fernández JR
    Expert Opin Pharmacother; 2020 Jul; 21(10):1167-1178. PubMed ID: 32543325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular risk of essential hypertension: influence of class, number, and treatment-time regimen of hypertension medications.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):315-27. PubMed ID: 23181712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction.
    Hermida RC; Ayala DE; Fernández JR; Mojón A
    Chronobiol Int; 2013 Mar; 30(1-2):68-86. PubMed ID: 23181592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronotherapy with conventional blood pressure medications improves management of hypertension and reduces cardiovascular and stroke risks.
    Hermida RC; Ayala DE; Smolensky MH; Fernández JR; Mojón A; Portaluppi F
    Hypertens Res; 2016 May; 39(5):277-92. PubMed ID: 26657008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does Timing of Antihypertensive Medication Dosing Matter?
    Hermida RC; Hermida-Ayala RG; Smolensky MH; Mojón A; Crespo JJ; Otero A; Ríos MT; Domínguez-Sardiña M; Fernández JR
    Curr Cardiol Rep; 2020 Aug; 22(10):118. PubMed ID: 32772186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ingestion-time differences in the pharmacodynamics of dual-combination hypertension therapies: Systematic review and meta-analysis of published human trials.
    Hermida-Ayala RG; Mojón A; Fernández JR; Smolensky MH; Hermida RC
    Chronobiol Int; 2022 Apr; 39(4):493-512. PubMed ID: 34906002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sleep-time ambulatory blood pressure as a prognostic marker of vascular and other risks and therapeutic target for prevention by hypertension chronotherapy: Rationale and design of the Hygia Project.
    Hermida RC
    Chronobiol Int; 2016; 33(7):906-36. PubMed ID: 27221952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of age and hypertension treatment-time on ambulatory blood pressure in hypertensive patients.
    Hermida RC; Ayala DE; Crespo JJ; Mojón A; Chayán L; Fontao MJ; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):176-91. PubMed ID: 23077974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.